Nama's AI scorecard currently rates Sabra Health Care REIT Sell (4.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is SBRA's P/E ratio?

Sabra Health Care REIT trades at a trailing price-to-earnings ratio of 31.9.

When does SBRA report earnings?

Sabra Health Care REIT's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $0.18.

What is the SBRA price target?

The median analyst price target from 14 analysts is $22.00, with a range of $19.00 – $25.00.

Is SBRA Shariah compliant?

Nama's AAOIFI-style screen reads Sabra Health Care REIT as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does SBRA pay a dividend?

Yes — Sabra Health Care REIT's dividend yield is 5.7%.

Nama Insights

Sabra Health Care REIT (SBRA)

Real Estate · Reit Healthcare Facilities · NASDAQ

Sabra Health Care REIT (SBRA) is a Real Estate company in the Reit Healthcare Facilities industry. It has a market capitalization of $5.51B and a trailing price-to-earnings ratio of 31.9. Over the most recent reported fiscal year, revenue grew 10.2%. Nama's AI scorecard rates it Sell, 4.1 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Sell · 4.1/10

Negative, at the mild end of Sell. As of Nov 7, 2026.

Momentum

Lagging · -0.6% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-7.7%

How far the last close sits under the highest price of the past five years.

Market cap	$5.51B
Trailing P/E	31.9
Price / book	1.9
Price / sales	6.2
FCF yield	—
Dividend yield	5.7%
Gross margin	61.8%
Operating margin	18.7%
Net margin	7.6%
Revenue growth (YoY)	+10.2%
Revenue growth (3-yr annual)	+7.4%
EPS growth (YoY)	+22.9%
FCF/share growth (YoY)	—
Beta	0.6
Exchange	NASDAQ
Sector	Real Estate
Industry	Reit Healthcare Facilities

SBRA earnings

Next report: Feb 11, 2027 (Q4 2026, EPS estimate $0.18). Beat the EPS estimate in 1 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 2, 2026	$0.19	$0.17	+11.8%	$249.56M
Q2 2026	Aug 3, 2026	$0.15	$0.17	-11.8%	$235.87M
Q1 2026	Apr 29, 2026	$0.16	$0.16	+0.0%	$221.75M
Q4 2025	Feb 12, 2026	$0.16	$0.16	+0.0%	$211.90M

SBRA analyst price target

Median target $22.00 from 14 analysts, ranging $19.00 – $25.00.

Reit Healthcare Facilities peers

Ticker	Company	Market cap	P/E
WELL	Welltower	$179.74B	106.1
VTR	Ventas	$46.93B	164.3
OHI	Omega Healthcare Investors	$15.34B	17.6
DOC	Healthpeak Properties	$14.71B	40.5
AHR	American Healthcare REIT	$12.62B	103.4
CTRE	CareTrust REIT	$9.03B	25.1
HR	Healthcare Realty Trust	$6.66B	—
NHI	National Health Investors	$3.50B	21.1

Explore live SBRA data on Nama Insights →

SBRA FAQ

Is SBRA a buy?: Nama's AI scorecard currently rates Sabra Health Care REIT Sell (4.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is SBRA's P/E ratio?: Sabra Health Care REIT trades at a trailing price-to-earnings ratio of 31.9.
When does SBRA report earnings?: Sabra Health Care REIT's next scheduled report is on Feb 11, 2027. Analysts expect EPS of $0.18.
What is the SBRA price target?: The median analyst price target from 14 analysts is $22.00, with a range of $19.00 – $25.00.
Is SBRA Shariah compliant?: Nama's AAOIFI-style screen reads Sabra Health Care REIT as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does SBRA pay a dividend?: Yes — Sabra Health Care REIT's dividend yield is 5.7%.